5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Asia-Pacific Bariatric Surgery Market is segmented by Device (Assisting Devices, Implantable Devices, and Other Devices) and Geography.
The Asia-Pacific Bariatric Surgery Market is expected to register a CAGR of 8.5% during the forecast period. The key factors propelling the growth of the Asia pacific bariatric surgery market is the increase in the number of obese patients and the rising prevalence rate of type-2 diabetes and heart diseases.
Obesity is considered a metabolic dysfunction and is often associated with a wide range of chronic illnesses that cause significant increases in mortality. Obesity is found to be associated with substantial increases in premature mortality, impaired quality of life, and a substantial amount of healthcare costs.
As per Australian Bureau of Statistics’ National Health Survey, in 2017-2018, about two thirds (67%) of Australian adults were overweight or obese (12.5 million people), up from 63.4% in 2014-2015. It is also indicated that almost one quarter (24.9%) of children who are aged 5-17 years were overweight or obese in 2017-2018 (17% overweight and 8.1% obese).
In addition, the emergence of new technologies in bariatric surgery and growing demand for minimally invasive surgical procedures that are acting as the key drivers for the market growth during the forecast period. Thus, bariatric surgery market in Asia-Pacific is expected to show significant growth over the forecast period.
As per the scope of the report, bariatric surgery is a medical procedure that aids the weight loss by either limiting the capacity of the stomach or the absorption of the calories. This is the most effective weight loss therapy available for patients with morbid obesity, and it involves either open or laparoscopic techniques. The Asia-Pacific Bariatric Surgery Market is segmented by the device (assisting devices, implantable devices and other devices).
Report scope can be customized per your requirements. Click here.
The stapling devices segment is expected to show a comparatively higher growth rate over the forecast period, as compared to other devices used in the bariatric surgeries. It is the most commonly used device, as it tends to result in greater and more consistent weight loss among patients, along with a greater reduction in obesity-related health problems. As per Ministry of Health, Labour and Welfare of Japan (MHLW), in 2017, approximately 19.4% of female adults who were aged 20 years and over were overweight, up from around 19% in 2016. Thus, owing to the increasing prevalence of obesity the segment is expected to show significant growth in the coming years.
To understand key trends, Download Sample Report
The Asia-Pacific Bariatric Surgery Market is consolidated competitive. The manufacturers are innovating new technologies, which are non-invasive, for reducing patients’ time in the hospitals, decreasing the chances of infection, and saving the cost. Additionally, smaller players are implementing strategies, such as acquisitions, to expand their product portfolio and gain roots in the industry.
1.1 Study Assumptions
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Obesity Patients
4.2.2 Government Initiatives to Curb Obesity
4.2.3 Rising Prevalence of Type 2 Diabetes and Heart Diseases
4.3 Market Restraints
4.3.1 High Cost of Surgery
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Device
5.1.1 Assisting Devices
184.108.40.206 Suturing Device
220.127.116.11 Closure Device
18.104.22.168 Stapling Device
22.214.171.124 Other Assisting Devices
5.1.2 Implantable Devices
126.96.36.199 Gastric Bands
188.8.131.52 Electrical Stimulation Devices
184.108.40.206 Gastric Balloons
220.127.116.11 Gastric Emptying
5.1.3 Other Devices
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Johnson and Johnson (Ethicon Inc)
6.1.3 Olympus Corporation
6.1.4 Conmed Corporation
6.1.5 Apollo Endosurgery Inc
6.1.6 Intuitive Surgical Inc
6.1.7 B. Braun Melsungen AG
6.1.8 ReShape Lifesciences Inc
6.1.9 GI Dynamics
6.1.10 The Cooper Companies
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments